{"id":24727,"date":"2019-09-03T00:00:00","date_gmt":"2019-09-03T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2019\/09\/03\/complete-revascularization-best-for-stemi-with-multivessel-cad\/"},"modified":"2019-09-04T16:06:08","modified_gmt":"2019-09-04T16:06:08","slug":"complete-revascularization-best-for-stemi-with-multivessel-cad","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2019\/09\/03\/complete-revascularization-best-for-stemi-with-multivessel-cad\/","title":{"rendered":"Complete Revascularization Best for STEMI With Multivessel CAD"},"content":{"rendered":"<h3>Complete revascularization better than culprit lesion-only percutaneous coronary intervention<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, Sept. 3, 2019 (HealthDay News) &#8212; For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete revascularization is superior to culprit lesion-only percutaneous coronary intervention (PCI), according to a study published online Sept. 1 in the <i>New England Journal of Medicine<\/i>. The research was published to coincide with the European Society of Cardiology Congress 2019, held from Aug. 31 to Sept. 4 in Paris.<\/p>\n<p>Shamir R. Mehta, M.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues randomly assigned patients with STEMI and multivessel coronary artery disease who had undergone successful culprit-lesion PCI to either a strategy of complete revascularization with PCI of angiographically significant nonculprit lesions or no further revascularization. Patients were followed for a median of three years.<\/p>\n<p>The researchers found that the first coprimary outcome (composite of cardiovascular death or myocardial infarction) occurred in 7.8 and 10.5 percent of patients in the complete-revascularization and culprit lesion-only PCI groups, respectively (hazard ratio, 0.74). The second coprimary outcome (composite of cardiovascular death, myocardial infarction, or ischemia-driven revascularization) occurred in 8.9 and 16.7 percent of patients, respectively (hazard ratio, 0.51). Regardless of the intended timing of nonculprit-lesion PCI, the benefit of complete revascularization was seen consistently for both coprimary outcomes.<\/p>\n<p>&#8220;In light of the results of the well-planned and well-executed trial by Mehta et al., the guidelines should recommend a strategy of full revascularization in patients with STEMI and multivessel disease, at least in those who have suitable nonculprit lesions,&#8221; write the authors of an accompanying editorial.<\/p>\n<p>The study was partially funded by AstraZeneca and Boston Scientific.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1907775\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe1910898\" target=\"_new\" rel=\"noopener noreferrer\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.escardio.org\/Congresses-&#038;-Events\/ESC-Congress\" target=\"_new\" rel=\"noopener noreferrer\">More Information<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2019 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Complete revascularization better than culprit lesion-only percutaneous coronary intervention<\/p>\n","protected":false},"author":6,"featured_media":24798,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-24727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/24727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=24727"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/24727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/24798"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=24727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=24727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=24727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}